Close

Rating History for Intra-Cellular Therapies (ITCI) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for ITCI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/17/2024 Jason Gerberry Maintain Buy
(N/A)		 91.00
(82.00)		  
 		   Details